Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-25-085030
Filing Date
2025-09-05
Accepted
2025-09-05 16:15:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8369
  Complete submission text file 0001213900-25-085030.txt   9999
Mailing Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404 1-650-209-4055
Apollomics Inc. (Subject) CIK: 0001944885 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94041 | Film No.: 251296922
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address NO.89, SONGREN RD., XINYI DIST. TAIPEI CITY 11073 F5 5F-4
Business Address NO.89, SONGREN RD., XINYI DIST. TAIPEI CITY 11073 F5 5F-4 886277137952
Maxpro Investment Co., Ltd (Filed by) CIK: 0002023743 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G/A